Why Controlling Critical Material Attributes Matters in Pharmaceutical Technology Transfer: Your process was validated. Your equipment matches. Your batch records are identical. Yet the receiving site still struggles to reproduce the sending site’s results. The root cause is often hiding in a place no one thought to look: the raw materials.
Risk Evaluation in Biopharmaceutical Technology Transfer: Why a Risk-Based Approach Is Essential for GMP Success. Successful biopharmaceutical technology transfer depends on more than process knowledge.
Tagged : Biopharmaceutical, Compliance, GxP, MSAT, QRM, Quality 4.0, Risk Management, Technology Transfer
Health Canada has released a new Draft Good Manufacturing Practices (GMP) Guide for Natural Health Products (NHPs), marking a significant update in the regulation of supplements, herbal remedies, vitamins, and other natural health products in Canada. If you’re a manufacturer, distributor, or consumer of NHPs, this draft guide is worth paying attention to—it could shape
In today’s rapidly evolving biotechnology landscape, regulatory challenges often determine the difference between groundbreaking innovations that reach patients and those that remain trapped in development limbo. We’re excited to announce the release of our comprehensive white paper, “Navigating the Regulatory Landscape: 10 Critical Challenges for Biotech Companies,” designed to help innovators chart a successful course
Good Manufacturing Practice (GMP) quality compliance is a cornerstone of the biopharmaceutical industry, ensuring that products are consistently produced and controlled according to high standards. As artificial intelligence (AI) and machine learning (ML) find increasing applications across the sector, it’s essential to consider how quality management processes need to evolve. Incorporating AI into biopharmaceuticals can